Study at a glance
What question did the studies ask?
Researchers asked how gene activity responds to vitamin D in different cells, tissues and time periods. RNA messages are copied from genes. Measuring RNA is different from measuring a protein or how well a tissue works.
What did the researchers find?
A laboratory model of human immune cells, grown from a blood cancer, showed dependence on the vitamin D receptor. Removing this protein prevented the detected response to calcitriol, the active vitamin D hormone, under those conditions. This does not establish that every vitamin D response works identically.
Human intestinal cells grown in the laboratory responded differently by gut region and by how developed the cells were. Another study showed that a gene-message increase could occur before a detectable protein increase. These experiments did not establish the proposed clinical benefits.
A study of 25 healthy adults found selected blood-cell changes one day after vitamin D3, without an inactive comparison group. A separate year-long trial assigned older adults by chance to vitamin D3 or an inactive comparison treatment. It did not find a clear whole-blood gene response under its analysis. The studies differed in population, exposure, timing and measurement.
What does this mean?
The responses differed between cell types and conditions. A changed gene message does not automatically mean better tissue function. Laboratory active-hormone treatment and oral vitamin D3 are different interventions, and these studies do not establish a personal dose.
Read the full article below ↓Vitamin D-responsive gene expression varies with cell type, tissue segment, differentiation state, exposure and sampling time. A response in a cultured cell line, a short blood response after vitamin D3 and a later randomized whole-blood result therefore answer different questions. This review compares those outputs without assuming one gene programme operates throughout the body or that changed RNA establishes improved physiological function. For the shorter account, read Vitamin D-Responsive Gene Expression Across Cells and Tissues: Study Summary.
What is being compared?
Transcription produces RNA messages from genes. RNA abundance is one layer of regulation, rather than a direct measure of protein abundance, tissue function or health. Vitamin D signalling can affect that layer through the vitamin D receptor, abbreviated VDR, and other regulatory proteins. Vitamin D and Gene Expression introduces gene expression, while Vitamin D and Transcription Factors explains transcription-factor cooperation. The receptor belongs to the family described in Vitamin D and Nuclear Receptors.
This is a focused comparison of primary experiments, not a pooled estimate of a universal gene response. The studies differ in exposure, comparator, cellular state and statistical definition. Significant-gene counts cannot be ranked as if they measured how strongly each tissue benefits. More samples, a more variable model, a different threshold or a later measurement can change the number detected. Distinct assays within a paper remain parts of one study, not extra independent replications.
Calcitriol is the active vitamin D hormone. Giving it directly to cells is different from oral cholecalciferol, or vitamin D3, which the body must process. Removing VDR is different again: it tests receptor dependence, not simply low dietary supply. Vitamin D Receptors provides that receptor context. The research amounts below describe methods, not personal treatment instructions.
A receptor-knockout monocyte model
Warwick and colleagues compared human THP-1 monocytic leukaemia cells with VDR deleted against a non-targeting control. Cells received 100 nanomoles per litre calcitriol, with RNA measured at four and 24 hours. The transcriptomic comparison used one knockout clone and one control clone, with four biological RNA-sequencing repeats. Validation of several edited lines did not make the RNA experiment a comparison of several independent knockout clones. [1]
The control had 109 significantly responsive genes at four hours and 1,341 at 24 hours. None met the tested response criteria in the knockout. This strongly supports receptor dependence of the detected transcriptional response in this particular model. It does not establish the literal absence of every molecular response in every tissue, and it cannot exclude rapid effects that were not measured by the RNA assay. A leukaemia-derived line also differs from a normal circulating monocyte. [1]
Network analysis linked early regulatory genes with later responses, but most proposed connections were predictions rather than fully tested causal edges. Earlier binding and accessibility datasets were reused. Those data strengthen the integrated analysis without becoming independent confirmations each time they are reanalysed. The changing four-hour and 24-hour results illustrate why timing belongs in the scientific question rather than being treated as a minor technical detail. [1]
Human intestinal cultures: segment and cell state matter
Criss and colleagues compared six duodenal and six proximal-colon culture lines from nine donors; three people supplied both tissues. Differentiated and undifferentiated cultures received 100 nanomoles per litre calcitriol for 24 hours versus vehicle. Three pooled wells per condition were not three independent human donors. The study therefore compared both anatomical segment and cellular state within a donor-based laboratory system. [2]
At the stated 5% false-discovery threshold, responsive-gene counts were 836 and 1,900 in undifferentiated and differentiated duodenal cultures, and 174 and 1,112 in the corresponding colon conditions. Only 63 genes were shared across all four comparisons. Donor, state and segment accounted for more transcriptomic variation than treatment in the reported analysis. This is evidence for context-dependent output, not a single intestinal response copied into every cell. [2]
Some commonly responsive genes included established vitamin D-related targets, but many responses depended on segment or differentiation state. Changed RNA for a regulatory protein did not prove assembly or necessity of its entire protein complex. Likewise, pathway enrichment concerning barrier, drug metabolism or wound functions was not a measurement of those functions: the authors reported no functional experiments. The distinction between a differentiated state and a measured developmental transition is explained in Vitamin D and Cell Differentiation. [2]
Binding information was imported from other culture and cell-line datasets rather than newly measured in every donor and condition. Twenty-four hours can include primary and secondary effects. An internal statement about one transporter being induced only in the duodenum conflicts with colon results, so tissue exclusivity cannot be assumed from that sentence. The broad segment/state comparison remains useful without promoting an unresolved single-gene claim. [2]
A short human blood response after vitamin D3
Ghosh Dastidar and colleagues studied 25 healthy Finnish adults aged 21 to 54 years after a single 80,000-international-unit vitamin D3 bolus split between breakfast and lunch. Peripheral blood mononuclear cells, a mixture of immune-cell types, were sampled before treatment and 24 hours later. There was no placebo or untreated same-time comparison. The participants were not an exclusively vitamin-D-deficient group. [3]
The analysis identified 452 responsive genes among 9,374 expressed protein-coding genes, with 181 higher and 271 lower. Enrichment highlighted focal-adhesion-related functions, but the study did not directly measure immune-cell migration, adhesion, resistance to infection or clinical benefit. A pathway label also does not mean every participant changed in the same direction. Blood-cell composition and ordinary changes over time remain alternative explanations in an uncontrolled before-and-after design. [3]
The reported in-vitro overlaps used cells or datasets from the same 25-person pool, including subsets and repeated single-person analyses. They were not four independent replications. Cell experiments used calcitriol, not oral vitamin D3, and some binding assignments borrowed THP-1 information rather than participant-specific receptor-occupancy measurements. These are complementary comparisons with important exposure and independence limits. [3]
A longer randomized human comparison
BEST-D randomized 305 community-dwelling adults aged at least 65 years to 2,000 or 4,000 international units of vitamin D3 daily or placebo for 12 months. Gene-expression data were available for 298 participants, with 262 complete baseline/end pairs. Blood vitamin D levels rose substantially in the active arms. The controlled analysis nevertheless found no genes meeting a 5% false-discovery threshold and no convincing change in the selected circulating cytokines. [4]
This is a material human null result, not an invitation to choose nominal within-treatment findings instead of the randomized comparison. However, whole blood is a cell mixture, and one late measurement can miss earlier or rare-cell responses. This older population was not selected specifically for severe deficiency. The result therefore limits a broad late whole-blood response under these regimens without disproving every cell, tissue or time-specific response. It illustrates the distinction in Vitamin D Status vs Vitamin D Effect. [4]
The short Finnish and longer BEST-D results should not be made to agree by ignoring their differences, or declared contradictory solely because one detected genes and the other did not. Age, exposure pattern, sample compartment, comparator and timing differ. A placebo-controlled late contrast supports a different attribution from an uncontrolled 24-hour comparison. Neither measures the complete response of every responsive tissue. [3] [4]
An earlier pilot compared 400 with 2,000 international units of vitamin D3 daily for eight weeks. Eight people completed it. The pooled before-and-after analysis reported 291 responsive genes under its selected threshold, but there was no placebo and no significant dose-group difference. Randomization of the two doses does not give the pooled time comparison placebo-controlled causal status. This is a weak historical qualification, not proof that changed expression improves immunity or clinical health. [5]
Donor genotype and RNA-to-protein timing
Witonsky and colleagues studied human donor-derived colon organoids, combining RNA, accessibility, genotype and selected protein measurements after calcitriol. The broad transcriptional responses across the ancestry groups were strongly correlated; the study did not establish a stronger overall absolute response in one group. Precise ancestry-specific donor accounting differs across the main text, methods and supporting tables, so those subgroup numbers cannot responsibly be reconstructed by guessing. [6]
At the POLB locus, a regulatory insertion/deletion was investigated with reporter constructs and receptor-binding tests. This is stronger evidence than a predicted DNA motif alone, but not selective editing of the endogenous variant or proof of every gene: variant assignment. RNA was measured at six hours and selected protein responses at six and 24 hours. POLB RNA could rise without a protein rise at the earlier time, followed by genotype-related protein differences later. [6]
The experiment therefore supplies a concrete reason not to treat an RNA change as an immediate protein or functional outcome. Accessibility, RNA, protein and reporter assays are complementary components of one programme. No direct DNA-repair performance, cancer prevention or clinical treatment-response endpoint was measured. The relationship between accessibility and gene activity is developed in Vitamin D and Epigenetic Regulation. [6]
Two regulatory routes in fibrosis experiments
Ito and colleagues studied a nonclassical VDR route involving SMAD3, a regulator of fibrosis-associated transcription. Purified VDR and SMAD3 domains interacted, and receptor variants unable to bind the usual vitamin D response elements could still repress a SMAD-dependent reporter. Selected fibrogenic transcripts fell without an equivalent reduction in the upstream TGF-beta transcript or SMAD3 phosphorylation. This is altered transcription through a partner pathway, not evidence of no transcription or proof of a rapid nontranscriptional response. [7]
Ding and colleagues instead examined liver stellate cells under TGF-beta signalling. The stimulus altered the VDR binding landscape; selected VDR recruitment was followed by reduced SMAD3 occupancy. VDR depletion reversed the tested repression/occupancy reduction, while SMAD depletion reduced inducible receptor binding. These genomic tests are distinct from the purified-domain interaction in the renal study. Nearby-gene assignments and selected occupancy experiments do not make every bound site a proven causal target. [8] [7]
The associated mouse injury findings provide a tissue context, but a synthetic ligand in a liver model and calcitriol in renal experiments are not ordinary oral vitamin D3 trials. This comparison concerns how regulatory output is generated, not a general claim that supplements improve injured organs. [8] [7]
From transcription to physiological consequences
The causal sequence requires separate measurements. RNA may change before a protein, and protein abundance may change without a demonstrated tissue benefit. The POLB timing experiment directly illustrates the first gap. The intestinal study illustrates another: enrichment for a barrier or wound-related category did not measure barrier passage or wound recovery. The acute human blood study likewise did not measure the migration suggested by its pathway labels. These omissions are part of the answer, rather than evidence that the proposed functions are impossible. [6] [2] [3]
A regulatory experiment can strengthen attribution by deleting a receptor or perturbing a partner. Yet clone effects, cell state and the particular reporter still constrain transfer to another tissue. Human randomized comparisons strengthen attribution for their measured compartment and time, while a late whole-blood null can leave other questions open. This is why an expression finding needs a clearly stated model, intervention, comparator, assay and time before being connected to physiology. [1] [7] [8] [4]
| Comparison | Observed result | Interpretive limit |
|---|---|---|
| THP-1 knockout versus control | Detected calcitriol RNA responses depended on VDR in this model | One clone per genotype; not all tissues or rapid signalling |
| Intestinal segment and differentiation state | Large differences in detected response sets | No direct functional test; donors and culture states matter |
| 24-hour human blood versus one-year randomized whole blood | Short uncontrolled signals coexist with a controlled late null | Different populations, exposure patterns, compartments and times |
| POLB RNA versus protein | Earlier RNA rise need not coincide with a protein rise | Neither result alone measures DNA-repair function |
| Renal partner repression versus liver genomic occupancy | Different routes to altered transcription | Not one universally proven protein interface or clinical intervention |
The strongest conclusion is that vitamin D-responsive transcription is conditional rather than uniform. Receptor-dependent cell experiments, regional human cultures, short blood responses and a longer randomized null make complementary contributions. They establish neither one universal gene programme nor an automatic health benefit from changing RNA. The scientifically useful question remains which response occurred, in which cells, at what time and with what further evidence of function.
Scientific sources
[1] A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick T, Schulz MH, Günther S, Gilsbach R, Neme A, Carlberg C, Brandes RP, Seuter S. Scientific reports. 2021;11(1):6518. DOI 10.1038/s41598-021-86032-5; PMID 33753848; PMCID PMC7985518.
[2] Analysis of 1,25-dihydroxyvitamin D genomic action in human enteroids and colonoids reveals multiple regulatory effects of vitamin D in human intestinal physiology. Criss ZK, Deans-Fielder K, Fleet JC, Christakos S, Shroyer N. Frontiers in endocrinology. 2025;16:1538463. DOI 10.3389/fendo.2025.1538463; PMID 40535337; PMCID PMC12173921.
[3] In vivo vitamin D targets reveal the upregulation of focal adhesion-related genes in primary immune cells of healthy individuals. Ghosh Dastidar R, Jaroslawska J, Malinen M, Tuomainen TP, Virtanen JK, Bendik I, Carlberg C. Scientific reports. 2024;14(1):17552. DOI 10.1038/s41598-024-68741-9; PMID 39080417; PMCID PMC11289414.
[4] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.
[5] Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. Hossein-nezhad A, Spira A, Holick MF. PloS one. 2013;8(3):e58725. DOI 10.1371/journal.pone.0058725; PMID 23527013; PMCID PMC3604145.
[6] Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB. Witonsky D, Laxman B, Usman H, Bielski MC, Lawrence KM, Kupfer SS. PLoS genetics. 2026;22(1):e1011983. DOI 10.1371/journal.pgen.1011983; PMID 41505470; PMCID PMC12810902.
[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.
[8] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.
Related reading
1,25-Dihydroxyvitamin-D3 Induces Avian β-Defensin Gene Expression in Chickens
Host defense peptides (HDPs) play a critical role in innate immunity.
Original paper ↗Read more →Adipose tissue inflammation and VDR expression and methylation in colorectal cancer
Lack of vitamin D (VD) has been associated with colorectal cancer (CRC).
Original paper ↗Read more →Defective Integrator activity shapes the transcriptome of patients with multiple sclerosis
High-depth RNA sequencing reveals down-regulation of HP1α/CBX5 in monocytes of multiple sclerosis patients, associated with major transcriptomic changes and reduced activity of the Integrator complex.
Original paper ↗Read more →Effects of fish and krill oil on gene expression in peripheral blood mononuclear cells and circulating markers of inflammation: a randomised controlled trial
In an 8-week trial, healthy men and women aged 18 to 70 years with fasting TAG of 1·3 to 4·0 mmol/l were randomised to receive krill oil capsules (n 12), HOSO capsules (n 12) or lean and fatty fish (n 12).
Original paper ↗Read more →Evaluation of MMP-9, IL-6, TNF-α levels and peripheral blood mononuclear cells genes expression of MMP-9 and TIMP-1 in Iranian patients with coronary artery disease
A considerable increase in levels and PBMC gene expression of MMP-9 and serum levels of IL-6 and TNF-α were found in CAD patients compared with controls.
Original paper ↗Read more →Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial
Elucidating the mechanisms of action of drug treatments in humans is challenging, but application of functional genomic approaches in randomized trials may afford an opportunity to systematically assess molecular responses.
Original paper ↗Read more →Influence of Vitamin D Status and Vitamin D3 Supplementation on Genome Wide Expression of White Blood Cells: A Randomized Double-Blind Clinical Trial
The objective of this study was to determine the effect of vitamin D status and subsequent vitamin D supplementation on broad gene expression in healthy adults.
Original paper ↗Read more →Integrated Transcriptomic and Metabolomic Profiling Reveals Candidate Genes and Metabolites Associated with Abdominal Fat Deposition in Pekin Ducks
Excessive abdominal fat deposition is undesirable in meat ducks because abdominal fat is usually discarded during processing and may reduce carcass value.
Original paper ↗Read more →Smoking decreases the response of human lung macrophages to double-stranded RNA by reducing TLR3 expression
We investigated whether smoking reduces expression by human lung macrophages (Mø) of receptors for viral nucleic acids and, if so, the effect on CXCL10 production.
Original paper ↗Read more →Tissue-Specific VDR Pathway Gene Expression Is Not Associated with Circulating 25OHD in Adolescents with Severe Obesity
This study examined the expression patterns of VDR-target genes across metabolically diverse tissues and compared these molecular measures with circulating serum 25-hydroxyvitamin D (25OHD), the current clinical marker of vitamin D status.
Original paper ↗Read more →Vitamin D and IFN-β Modulate the Inflammatory Gene Expression Program of Primary Human T Lymphocytes
IFN-β treatment is a commonly used therapy for relapsing-remitting multiple sclerosis (MS), while vitamin D deficiency correlates with an increased risk of MS and/or its activity.
Original paper ↗Read more →Vitamin D elicits tissue-specific isoform expression in Atlantic salmon muscles
To determine how an essential micronutrient alters muscle isoform production, we examined how vitamin D supplementation influences transcription at multiple hierarchical levels across four Atlantic salmon (Salmo salar) muscle tissues.
Original paper ↗Read more →Vitamin D Status Modulates Inflammatory Response in HIV+ Subjects: Evidence for Involvement of Autophagy and TG2 Expression in PBMC
We aimed to characterize the possible influence of vitamin D status on changes in expression of tissue transglutaminase gene (TGM2) and other genes involved in inflammatory response and autophagy in peripheral blood mononuclear cells (PBMC) from HIV+ subjects.
Original paper ↗Read more →A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes
The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).
Original paper ↗Read more →Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB
In our study, we aimed to understand how active vitamin D affects colon cells from people with African and European backgrounds.
Original paper ↗Read more →Diverse Regulation of Vitamin D Receptor Gene Expression by 1,25-Dihydroxyvitamin D and ATRA in Murine and Human Blood Cells at Early Stages of Their Differentiation
Vitamin D receptor (VDR) is present in multiple blood cells, and the hormonal form of vitamin D, 1,25-dihydroxyvitamin D (1,25D) is essential for the proper functioning of the immune system.
Original paper ↗Read more →Vitamin D-Responsive Gene Expression Across Cells and Tissues: Study Summary
A plain-English account of how vitamin D gene responses differ across cell types, experimental settings and sampling times, including a longer randomized null.
Read more →Calcitriol stimulates gene expression of cathelicidin antimicrobial peptide in breast cancer cells with different phenotype
Tumorigenicity was evaluated for each cell line in athymic mice.
Original paper ↗Read more →Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors
This study aimed to investigate the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Original paper ↗Read more →Investigating the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors
This study aimed to investigate the level of vitamin D receptor gene expression in two tumoral and healthy breast tissues in breast cancer patients and its association with prognostic factors.
Original paper ↗Read more →Vitamin D and Gene Expression
How vitamin D influences gene expression through vitamin D receptors, DNA response elements, transcription control, and changes in cellular behaviour.
Read more →Original sources
A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes
The transcription factor vitamin D receptor (VDR) is the high affinity nuclear target of the biologically active form of vitamin D3 (1,25(OH)2D3).
Publication details
[1] A hierarchical regulatory network analysis of the vitamin D induced transcriptome reveals novel regulators and complete VDR dependency in monocytes. Warwick T, Schulz MH, Günther S, Gilsbach R, Neme A, Carlberg C, Brandes RP, Seuter S. Scientific reports. 2021;11(1):6518. DOI 10.1038/s41598-021-86032-5; PMID 33753848; PMCID PMC7985518.
Analysis of 1,25-dihydroxyvitamin D genomic action in human enteroids and colonoids reveals multiple regulatory effects of vitamin D in human intestinal physiology.
Published in Criss ZK, Deans-Fielder K, Fleet JC, Christakos S, Shroyer N. Frontiers in endocrinology (2025).
Publication details
[2] Analysis of 1,25-dihydroxyvitamin D genomic action in human enteroids and colonoids reveals multiple regulatory effects of vitamin D in human intestinal physiology. Criss ZK, Deans-Fielder K, Fleet JC, Christakos S, Shroyer N. Frontiers in endocrinology. 2025;16:1538463. DOI 10.3389/fendo.2025.1538463; PMID 40535337; PMCID PMC12173921.
In vivo vitamin D targets reveal the upregulation of focal adhesion-related genes in primary immune cells of healthy individuals.
Published in Ghosh Dastidar R, Jaroslawska J, Malinen M, Tuomainen TP, Virtanen JK, Bendik I, Carlberg C. Scientific reports (2024).
Publication details
[3] In vivo vitamin D targets reveal the upregulation of focal adhesion-related genes in primary immune cells of healthy individuals. Ghosh Dastidar R, Jaroslawska J, Malinen M, Tuomainen TP, Virtanen JK, Bendik I, Carlberg C. Scientific reports. 2024;14(1):17552. DOI 10.1038/s41598-024-68741-9; PMID 39080417; PMCID PMC11289414.
Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.
[4] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial.
Publication details
[4] Genomic Response to Vitamin D Supplementation in the Setting of a Randomized, Placebo-Controlled Trial. Berlanga-Taylor AJ, Plant K, Dahl A, Lau E, Hill M, Sims D, Heger A, Emberson J, Armitage J, Clarke R, Knight JC. EBioMedicine. 2018;31:133-142. DOI 10.1016/j.ebiom.2018.04.010; PMID 29685792; PMCID PMC6013786.
Influence of Vitamin D Status and Vitamin D3 Supplementation on Genome Wide Expression of White Blood Cells: A Randomized Double-Blind Clinical Trial
The objective of this study was to determine the effect of vitamin D status and subsequent vitamin D supplementation on broad gene expression in healthy adults.
Publication details
[5] Influence of vitamin D status and vitamin D3 supplementation on genome wide expression of white blood cells: a randomized double-blind clinical trial. Hossein-nezhad A, Spira A, Holick MF. PloS one. 2013;8(3):e58725. DOI 10.1371/journal.pone.0058725; PMID 23527013; PMCID PMC3604145.
Genomic profiling of active vitamin D colonic responses in African- and European-Americans identifies an ancestry-related regulatory variant of POLB
In our study, we aimed to understand how active vitamin D affects colon cells from people with African and European backgrounds.
Publication details
[6] Genomic profiling of active vitamin D colonic responses in African: and European-Americans identifies an ancestry-related regulatory variant of POLB. Witonsky D, Laxman B, Usman H, Bielski MC, Lawrence KM, Kupfer SS. PLoS genetics. 2026;22(1):e1011983. DOI 10.1371/journal.pgen.1011983; PMID 41505470; PMCID PMC12810902.
A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis.
Publication details
[7] A nonclassical vitamin D receptor pathway suppresses renal fibrosis. Ito I, Waku T, Aoki M, Abe R, Nagai Y, Watanabe T, Nakajima Y, Ohkido I, Yokoyama K, Miyachi H, Shimizu T, Murayama A, Kishimoto H, Nagasawa K, Yanagisawa J. The Journal of clinical investigation. 2013;123(11):4579-4594. DOI 10.1172/jci67804; PMID 24135137; PMCID PMC3809783.
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
[8] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response.
Publication details
[8] A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Ding N, Yu RT, Subramaniam N, Sherman MH, Wilson C, Rao R, Leblanc M, Coulter S, He M, Scott C, Lau SL, Atkins AR, Barish GD, Gunton JE, Liddle C, Downes M, Evans RM. Cell. 2013;153(3):601-613. DOI 10.1016/j.cell.2013.03.028; PMID 23622244; PMCID PMC3673534.